Colorado Black Resource Directory connects patients with specialized health care
A new resource is bringing culturally appropriate health care providers to Black Coloradans. It's called the Colorado Black Health Resource Directory -- a collaboration between Colorado Black Health Collaborative and Connect for Health Colorado. The 108-page guide is the most comprehensive source of Black health information in Colorado and provides listings for doctors and specialists from Fort Collins to Pueblo.
"It's all encompassing," said Dr. Terri Richardson, co-founder of CBHR. "We go cradle to grave, that's what we say." Recently, she gathered with a group of fellow Black women to celebrate the release of CBHR. Richardson says the idea first came about in 2010, a response to requests for information from Black Coloradans seeking to connect with medical providers who understand their unique concerns. It's now in its fifth edition.
"People said, 'You know what we could use? A holistic view of health.' A guide. We wanted to cover the Black diaspora not just African Americans. Folks from all over," she told CBS News Colorado's Mekialaya White. According to the state of Colorado, in 2023, 4.18% of our population was Black or African American alone. It's a population that needs these resources, Richardson says.
"Sometimes, we feel like we get lost here in Colorado being only a small percentage of the population, yet our health disparities are at the top or the bottom as we always say."
Lielt Bedilu knows the struggle all too well. She says finding her current pediatrician, Dr. Sophia Meharena was an answered prayer. "There are things walking around as a Black individual that every day that you have to explain. You have to explain things about your culture, the way you speak, all these nuances, like your hair. I think the physician-patient relationship is so sacred, intimate, and vulnerable and my hope would be that we wouldn't have to do that in that space," she said. "It's not about being a better physician," explained Meharena. "It's about being able to connect with your patient in a way that the patient is looking for." But doctor by doctor, the directory works to make offices more welcoming. "It's very important to have someone with that lived experience. You don't have to explain to me what it means to be Black in America. I already know," added Richardson.
President Trump wants to dismantle the Department of Education. Here's what would be impacted.
Doctor calls Trump's vaccine order "theater" because no schools have COVID vaccine mandates
Saturday Sessions: Aloe Blacc performs "One Good Thing"
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
BioNTech will acquire all shares of CureVac after the two sides reached an agreement in a deal valued around $1.25 billion. Each share of CureVac, a clinical-stage biotech company, will be exchanged for about $5.46 in BioNTech American depositary shares. Upon the deal's closing, CureVac shareholders are expected to own between 4% and 6% of the German developer of RNA vaccines and immunotherapies. ICE Raids Have Sent Latino Shoppers Into Hiding and Big Brands Are Hurting The Secret to Retaining the Best Employees: Ask Them These Four Questions Here's How Much Money the U.S. Is Earning From Tariffs, in Charts How Home Depot Became Ground Zero in Trump's Deportation Push Supply Chains Become New Battleground in the Global Trade War BioNTech Chief Executive Ugur Sahin said the plan is to bring complementary capabilities between the two companies together to develop transformative cancer treatments. CureVac's operating subsidiary will become a wholly owned subsidiary of BioNTech following the close of the transaction. As part of this plan, BioNTech will integrate CureVac's research and manufacturing site in Tübingen, Germany. The deal was unanimously approved by both companies' management and supervisory boards. It is expected to close in 2025. Shares of CureVac surged 29% to $5.25 in premarket trading. Write to Denny Jacob at Pulls Outlook as Sales Fall Bojangles Is Exploring a Sale While the Fried-Chicken Market Is Hot Why Bosses Should Give Feedback in the Morning The Audacious Reboot of America's Nuclear Energy Program Muted May Inflation Defies Tariff Fears Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge
Most of UnitedHealth Group's issues should be temporary. The two biggest threats to the healthcare giant are iffy. The price is right to buy UnitedHealth Group stock after its steep decline. 10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) might want to change its stock ticker from "UNH" to "UGH." The latter better captures the feelings of the healthcare giant's shareholders in recent months. A string of problems has caused UnitedHealth Group's share price to plunge roughly 50% from the peak set in the fourth quarter of 2024. Some analysts have downgraded the stock, with HSBC recommending that investors reduce their holdings and slashing its price target. I have a different opinion, though. I think it's time to buy UnitedHealth Group stock. Here are three reasons why. I don't think investors should ignore UnitedHealth Group's issues. However, the challenges should be viewed with a long-term perspective. I suspect most of the problems the company faces should be temporary. UnitedHealth Group has already largely moved past the cyberattack that occurred in February 2024. Although it cost the healthcare company over $2 billion, that issue has already proven to be a short-lived one. Higher Medicare Advantage costs are the main culprit behind UnitedHealth Group's suspension of its 2025 full-year guidance. But the company says that it expects to return to growth in 2026. I believe this prediction because it makes sense. Insurers sometimes incur higher-than-anticipated costs and feel the pain for a while. However, once they adjust premiums, the problem goes away. UnitedHealth Group announced the sudden departure of former CEO Andrew Witty at the same time it withdrew its 2025 outlook. Any worries investors might have had surrounding this move probably dissipated quickly after they learned Stephen Hemsley was returning to run the company. Hemsley served as CEO from 2006 through 2017, a period when UnitedHealth Group stock more than tripled. I also view the two biggest threats to UnitedHealth Group as iffy. What are those threats? An alleged U.S. Department of Justice criminal investigation of the company and President Trump's stated goal to eliminate pharmacy benefits managers (PBMs). Noted that I used the word "alleged" to describe the U.S. Department of Justice probe. The Wall Street Journal reported on May 14, 2025, that "people familiar with the matter" revealed that the DOJ had launched a criminal investigation of UnitedHealth Group for possible Medicare fraud. However, the company quickly responded that it hadn't been notified of any DOJ investigation. That status hasn't changed. President Trump did announce that he wants to "cut out the middleman," a clear reference to PBMs. That's easier said than done, though, to put it mildly. Removing PBMs from the U.S. healthcare system would require a detailed, comprehensive plan that so far has not been provided. That plan would also have to pass in both the Senate and the House of Representatives. You can bet that the PBM industry, including UnitedHealth Group, would lobby fiercely against any such legislation. I think this threat, while serious, has a relatively low probability of actually materializing. Finally, I think all these issues are fully baked into UnitedHealth Group's share price. The stock currently trades at a forward price-to-earnings ratio of around 13.3. That's well below the S&P 500 healthcare sector forward earnings multiple of 16.6. It's also the lowest valuation for UnitedHealth Group in more than a decade. Could the stock fall further? Maybe, but I believe that UnitedHealth Group's share price has bottomed out. You might have noticed that UnitedHealth Group's share price has traded in a relatively narrow range since the steep decline in April and May. This trading pattern seems to confirm my view. Any good news for UnitedHealth Group could provide a nice catalyst. I predict that the company will have some positive developments in the not-too-distant future, potentially including new full-year guidance that calms investors. If I'm right, buying UnitedHealth Group stock now could pay off handsomely. Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 HSBC Holdings is an advertising partner of Motley Fool Money. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends HSBC Holdings and UnitedHealth Group. The Motley Fool has a disclosure policy. Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Newsweek
25 minutes ago
- Newsweek
Is Your Kitty Anxious? Be Aware of This Condition, Say Vets
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Cats are known to be skittish—but if yours is noticeably anxious, researchers are warning that you might want to be aware of one particular feline health condition. New research from the University of Montreal's Faculty of Veterinary Medicine has revealed a critical link between anxiety/stress and recurring bouts of a painful bladder condition—feline idiopathic cystitis (FIC). The team are urging cat owners and veterinarians to prioritize stress reduction for our more anxious furry companions. FIC is a leading cause of emergency vet visits and is characterized by acute bladder inflammation, painful and sometimes bloody urination in cats, according to the researchers. Traditionally, without detectable bacterial infections, stones or tumors, the condition is labeled as idiopathic—that is, with no "organic" cause. However, the team's study of 33 cats challenges this. A tabby cat hides and appears nervous. A tabby cat hides and appears nervous."A similar condition with the same symptoms occurs in women and is often linked to high levels of stress or anxiety," said veterinary behaviorist professor Marion Desmarchelier in a statement. "Some cats end up being euthanized because of it. The disease itself is not fatal, but the cost of repeated emergency treatments can be too much for some families." FIC has a high recurrence rate, with about half of affected cats having repeat episodes. A Connection With the COVID-19 Pandemic The University researchers also shed light on the connection between stress and cat health observed during the COVID-19 pandemic. When human companions stayed home, many cats—who are often known for their love of routine—found themselves disrupted. "We were home all the time during the pandemic," said paper co-author Marianne Caudron in a statement. "Dogs were thrilled because they got lots of walks, but we saw twice as many cases of idiopathic cystitis in cats." This observation prompted the team to launch their study, the results of which are published in the Journal of Veterinary Behavior. The research involved 33 cats diagnosed with FIC. Their owners completed a questionnaire about their cat's behavior—including their levels of aggression and fear—and details about their living environment. "We initially thought that anxious, aggressive cats would be more prone to recurrent cystitis, but it's actually the fearful, withdrawn ones that seem to be at greater risk," explained Desmarchelier. Treatment Should Focus on Mental Well-Being The study's authors advocate that the scope of FIC treatment should be expanded to include addressing cats' mental health. "We believe this condition is caused by stress and anxiety— and therefore should no longer be called idiopathic cystitis, but instead 'cystitis secondary to anxiety,'" Desmarchelier said. The study offered several practical ways to reduce feline stress, including increasing water sources in the home for cats, setting up an extra litter box than the number of cats in the home, offering a variety of toys and providing safe access to the outdoors. While these changes weren't shown to prevent all recurrences of cystitis, researchers believe they are crucial for risk reduction and overall well-being. Desmarchelier concluded with a hopeful message: "Taking a cat to the vet twice a year for a urinary blockage costs a fortune. But it doesn't have to be this way—there are solutions. That's the message we want to get across." Do you have a tip on a science story that Newsweek should be covering? Do you have a question about cats? Let us know via science@ Reference Caudron, M., Laroche, P., Bazin, I., & Desmarchelier, M. (2025). Association between behavioral factors and recurrence rate in cats with feline "idiopathic" cystitis. Journal of Veterinary Behavior, 78, 90–96.